Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
50 Patents
#10 in Plymouth, MN
#196 in Minnesota
#7,009 in US
#14,013 in the World
Atritech, Inc.
Forward Citations = 7,040
31 inventors:
Plymouth, MN, United States of America
Atritech, Inc.
% Expired Patents = 60.0
CIPO Patents = 1
EPO Patents = 4
Trademarks = 1
Forward Citations = 7,040
Loading Chart...
Loading Chart...
31 inventors (with patents filed for the assignee):
Erik Van Der Burg (22 out of 94 patents)
Andrew G C Frazier (21 out of 49 patents)
Chad C Roue (20 out of 76 patents)
4. Michael D Lesh (15 out of 110 patents)
5. Gregg Stuart Sutton (14 out of 57 patents)
6. Jeffrey M Welch (13 out of 33 patents)
7. Thomas E Borillo (12 out of 14 patents)
8. Robert G Hauser (11 out of 23 patents)
9. Marc S Kreidler (10 out of 35 patents)
10. Alexander K Khairkhahan (10 out of 113 patents)
11. Alan Klenk (9 out of 49 patents)
12. Robert A VanTassel (7 out of 19 patents)
13. Robert Schwartz (7 out of 8 patents)
14. David Holmes (7 out of 22 patents)
15. Chris Quinn (6 out of 7 patents)
Core Competencies:
Implant Delivery
Atrial Appendage
Blood Filtration
Occlusion Device
Expandable Implant
Intracardiac Cage
Embolic Material
Graft Securing
Detachable Balloon
Barrier Device
Retrieval System
Transseptal Sheath
50 patents:
1. 10898198 - Apparatus for delivering an implant without bias to a left atrial appendage (2021-01-26),
4. 10278805 - Expandable implant devices for filtering blood flow from atrial appendages (2019-05-07),
6. 10076335 - Apparatus for delivering an implant without bias to a left atrial appendage (2018-09-18),
Company Overview
Atritech, Inc., based in Plymouth, MN, specializes in innovative solutions for atrial appendage occlusion, a critical area in cardiac health. The company focuses on the development and manufacturing of advanced medical devices designed to enhance patient outcomes through effective blood filtration and occlusion techniques. Their core technologies include implant delivery systems, expandable implants, and intracardiac cages, aimed at securing grafts and preventing embolic events. Atritech is committed to advancing cardiac care through its specialized expertise.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Atritech, Inc.. Retrieved from https://idiyas.com/company/atritech
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]